Selective cell inactivation in blood
US5776966A · kind A · utility
17Cited by
9References
12Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | May 27, 1992 |
| Grant date | Jul 7, 1998 |
| Priority date | — |
| Expiry date | May 27, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment with a set of porphyrin compounds using a photodynamic therapy approach is able selectively to lower elevated levels of activated leukocytes in a leukocyte population. This is particularly helpful in subjects containing such elevated levels of T-cell subsets, such as HIV-infected subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.